Effect of Haoqin Qingdan Tang on influenza A virus through the Janus kinase/signal transducer and activator of transcription (JAK/ STAT) pathway

被引:2
|
作者
Liang, Shiyun [1 ]
Lin, Jieling [1 ]
Xiao, Mengjie [4 ]
Shi, Tongmei [1 ]
Song, Yu [4 ]
Zhang, Tianbo [5 ]
Zhou, Xi [4 ]
Li, Runfeng [3 ]
Zhao, Xin [4 ]
Yang, Zifeng [3 ,6 ,7 ,8 ]
Ti, Huihui [1 ,2 ]
机构
[1] Guangdong Pharmaceut Univ, Sch Chinese Mat Med, Guangzhou 510006, Peoples R China
[2] Guangdong Pharmaceut Univ, Guangdong Prov Precise Med Big Date Tradit Chinese, Guangzhou 510006, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis,State Key Lab Resp Dis, Guangzhou 510000, Peoples R China
[4] Guangdong Acad Sci, China Natl Analyt Ctr, Guangdong Prov Engn Res Ctr Ambient Mass Spectrome, Inst Anal,Guangdong Prov Key Lab Chem Measurement, Guangzhou 510070, Peoples R China
[5] Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA 94305 USA
[6] Guangzhou Lab, Guangzhou 510000, Peoples R China
[7] Guangzhou Key Lab Clin Rapid Diag & Early Warning, Guangzhou 510000, Peoples R China
[8] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa 519020, Macau, Peoples R China
基金
中国国家自然科学基金;
关键词
Haoqin Qingdan Tang; Influenza virus; JAK/STAT; Network pharmacology; HEAT SYNDROME; INFECTION; DECOCTION; DISEASE;
D O I
10.1016/j.phymed.2024.155680
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Objective: Influenza, a viral respiratory illness, leads to seasonal epidemics and occasional pandemics. Given the rising resistance and adverse reactions associated with anti-influenza drugs, Traditional Chinese Medicine (TCM) emerges as a promising approach to counteract the influenza virus. Specifically, Haoqin Qingdan Tang (HQQDT), a TCM formula, has been employed as an adjuvant treatment for influenza in China. However, the active compounds and underlying mechanisms of HQQDT remain unknown. Aim: The aim of this study was to investigate HQQDT ' s antiviral and anti-inflammatory activities in both in vivo and in vitro , and further reveal its active ingredients and mechanism. Methods: In vivo and in vitro experiments were conducted to verify the antiviral and anti-inflammatory activities of HQQDT. Subsequently, the active ingredients and mechanism of HQQDT were explored through combining high performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (HPLC-Q-TOF MS) analysis and network pharmacology. Finally, the examinations of cell cytokines and signaling pathways aimed to elucidate the predicted mechanisms. Results: The results indicated that HQQDT exhibited inhibitory effects on influenza viruses A/PR/8/34 (H1N1), A/HK/1/68 (H3N2), and A/California/4/2009 (H1N1) in vitro . Furthermore, HQQDT enhanced the survival rate of influenza-infected mice, reduced the lung index and lung virus titer, and mitigated lung tissue damage in vivo . The proinflammatory cytokine expression levels upon influenza virus infection in PR8-induced A549 cells or mice were suppressed by HQQDT, including IL-6, IL-1 beta , CCL 2 , CCL 4 , IP-10, interferon beta 1 (IFN- beta 1), the interferon regulatory factor 3 (IRF3), and hemagglutinin (HA). Twenty-two active components of HQQDT against influenza were identified using HPLC-Q-TOF-MS analysis. Based on network pharmacological predictions, the JAK/STAT signaling pathway is considered the most relevant for HQQDT ' s action against influenza. Finally, western blot assays revealed that HQQDT regulated the protein level of the JAK/STAT signaling pathway in PR8-infected A549 cells and lung tissue. Conclusion: These findings verified the antiviral and anti-inflammatory effects of HQQDT through JAK-STAT signaling pathway in influenza infections, laying the foundation for its further development.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] PILOT STUDY OF A PUTATIVE CROSSTALK BETWEEN JAK-STAT (JANUS KINASE - SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION) AND VDR (VITAMIN D RECEPTOR) IN ALOPECIA AREATA
    Thomas, Carla
    Heyne, Kristina
    Roemer, Klaus
    Saternus, Roman
    Lehr, Claus-Michael
    Mueller, Cornelia Sigrid Lissi
    Reichrath, Joerg
    Vogt, Thomas
    ANTICANCER RESEARCH, 2017, 37 (06) : 3354 - 3355
  • [32] FDA-Approved Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) Inhibitors for Managing Rheumatoid Arthritis: A Narrative Review of the Literature
    Potlabathini, Tejaswini
    Pothacamuri, Mounica A.
    Bandi, Venkata Varshitha
    Anjum, Mahnoor
    Shah, Parmendra
    Molina, M.
    Dutta, Nilashis
    Adzhymuratov, Oleksandr
    Mathew, Midhun
    Sadu, Vatsalya
    Zahid, Shiza A.
    Lingamgunta, Harini
    Sahotra, Monika
    Nasiri, Syed Muhammad Zain Jamil
    Daguipa, Christine Dawn M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [33] Activation of Janus kinase/signal transducer and activator of transcription 3 pathway by growth hormone-releasing hormone
    Agnieszka Siejka
    Andrew V. Schally
    Nektarios Barabutis
    Cellular and Molecular Life Sciences, 2010, 67 : 959 - 964
  • [34] Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies
    Mughal, Tariq I.
    Girnius, Saulius
    Rosen, Steven T.
    Kumar, Shaji
    Wiestner, Adrian
    Abdel-Wahab, Omar
    Kiladjian, Jean-Jacques
    Wilson, Wyndham H.
    Van Etten, Richard A.
    LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 1968 - 1979
  • [35] Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma
    Kashyap, Alisha
    Dai, Julia
    Ni, Xiao
    CANCERS, 2025, 17 (04)
  • [36] Role of Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway in cardioprotection of exercise preconditioning
    Sun, X-J
    Mao, J-R
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (15) : 4975 - 4986
  • [37] Activation of Janus kinase/signal transducer and activator of transcription 3 pathway by growth hormone-releasing hormone
    Siejka, Agnieszka
    Schally, Andrew V.
    Barabutis, Nektarios
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (06) : 959 - 964
  • [38] Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
    Berthier, Celine C.
    Zhang, Hongyru
    Schin, MaryLee
    Henger, Anna
    Nelson, Robert G.
    Yee, Berne
    Boucherot, Anissa
    Neusser, Matthias A.
    Cohen, Clemens D.
    Carter-Su, Christin
    Argetsinger, Lawrence S.
    Rastaldi, Maria P.
    Brosius, Frank C.
    Kretzler, Matthias
    DIABETES, 2009, 58 (02) : 469 - 477
  • [39] Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway
    Dang, Chun
    Lu, Yaoheng
    Chen, Xingyu
    Li, Qian
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [40] Members of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway are present and active in human sperm
    D'Cruz, OJ
    Vassilev, AO
    Uckun, FM
    FERTILITY AND STERILITY, 2001, 76 (02) : 258 - 266